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S U M M A R Y
Background: Data on inﬂuenza illness rates with population denominators are needed to quantify overall
morbidity and to prioritize public health intervention strategies.
Methods: The rates of inﬂuenza A(H1N1)pdm09 infection during pandemic phases were determined in a
longitudinal community cohort study as part of an inﬂuenza vaccine study in a rural community of North
India.
Results: During the 711 731 person-weeks of surveillance, a total of 1410/7571 (19%) febrile acute
respiratory illness cases were positive for inﬂuenza. Of these, 749 (53%) were inﬂuenza A(H1N1)pdm09,
643 (46%) inﬂuenza B, and 18 (1%) inﬂuenza A (H3N2). The overall incidence rate of inﬂuenza-associated
febrile acute respiratory illness was 128/1000 person-years. The incidence rates of inﬂuenza
A(H1N1)pdm09 were high during both the pandemic phase (179/1000 person-years; November
2009 to January 2010) and post-pandemic phase (156/1000 person-years; August to October 2010), with
children <18 years of age being at the greatest risk of inﬂuenza infection in the community.
Conclusions: These ﬁndings provide important information for planning clinical and public health
intervention strategies to mitigate the impact of inﬂuenza epidemics.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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A novel pandemic strain of inﬂuenza virus, A(H1N1)pdm09,
emerged in April 2009 and spread rapidly worldwide.1 Under-
standing the transmission dynamics and incidence of inﬂuenza,
especially in resource-constrained countries, where different co-
morbidities might lead to a different burden and epidemiology, are
important factors in devising public health responses and
mitigation strategies for pandemic inﬂuenza control.1,2
Serological surveys during the early part of the pandemic
suggested that the majority of naive populations would be
susceptible to A(H1N1)pdm09 infection.3 Indeed, several studies
established a consistent pattern of higher rates of A(H1N1)pdm09
infection in school-aged children relative to younger adults, with the* Corresponding author. Tel.: +1 205 996 7791; fax: +1 205 975 3221.
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http://dx.doi.org/10.1016/j.ijid.2013.08.005lowest rates observed in older adults.4–7 The majority of the
serological approaches to estimate the incidence of inﬂuenza
A(H1N1)pdm09 have used a non-cohort-based design by the testing
of longitudinal paired sera from pre- and post-pandemic phases or a
cross-sectional design where a cut-off threshold was established to
estimate exposure and/or infection.5–7 These studies underscore the
need to have better indicators for understanding the incidence rates
(IRs) of an epidemic along with population denominators to quantify
overall morbidity and to prioritize public health intervention
strategies.2 Modeling studies may have an important role in early
estimates of cumulative incidence; however, prospective cohort
studies, such as the one described here, are needed to provide the
actual community estimates of inﬂuenza incidence.
Population-based weekly active surveillance implemented
soon after the emergence of pandemic inﬂuenza in a rural
community in India8 provided an opportunity to determine the
overall incidence of A(H1N1)pdm09 during the ﬁrst inﬂuenza
pandemic of the 21st century. This information on magnitude,
age distribution, and seasonality of A(H1N1)pdm09 will be useful
for modeling disease burden, advocacy, and health system
planning.ses. Published by Elsevier Ltd. All rights reserved.
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2.1. Study population
During November 1, 2009 to October 31, 2010, all members of
the households residing in three villages located in the Ballabhgarh
sub-district of Faridabad, Haryana State in North India, were
eligible to enroll in the febrile acute respiratory illness (FARI)
surveillance component of an inﬂuenza vaccine trial of children
aged 6 months to 10 years within the same villages.8 The vaccine
trial is an ongoing prospective, longitudinal, phase IV, household-
randomized, controlled, observer-blinded 3-year study (2009–
2011) designed to measure the direct and indirect protective
effects of immunizing children aged 6 months through 10 years
with seasonal inactivated trivalent inﬂuenza vaccine (TIV) or a
control vaccine (http://www.ClinicalTrials.gov, NCT00934245).8
The 2009 northern hemisphere inﬂuenza vaccine administered in
December 2009 through January 2010 included strains: A/
Brisbane/59/2007 (H1N1), A/Brisbane/10/2007 (H3N2), and B/
Brisbane/60/2008. Pandemic virus was not a component of this
vaccine.
Members of 2806 households (enrollment rate >90% of eligible
cases) in the villages were enrolled in the FARI surveillance and
received weekly home visits, represented as epidemiologic weeks
(EW) throughout the year (no surveillance occurred in EW48 and
EW53 of 2009 due to vaccination efforts). If a household member
who was to be surveyed was not present at the time of the home
visit by the study trained surveillance ofﬁcer, proxy information
about possible FARIs was collected from an available adult in the
household. Possible FARI cases identiﬁed by the study surveillance
ofﬁcers were visited by nurses for conﬁrmation of case deﬁnition,
clinical assessment, and collection of specimens for inﬂuenza
testing. The study population was a dynamic study cohort under
weekly surveillance, with changes in the household composition
(marriages/moves and births/deaths) recorded in the study
database as reported throughout the year.
Written informed consent was obtained from each household
member for enrollment into the study. For children, consent from
their parents was obtained, and where appropriate, assent from
the child. Institutional review board approval was obtained from
the All India Institute of Medical Sciences, New Delhi, India, the
University of Alabama at Birmingham, Birmingham, and the
Centers for Disease Control and Prevention, Atlanta.
2.2. Case deﬁnition
FARI was deﬁned as a history (current or in the preceding week)
of fever with any of the following respiratory complaints: cough,
sore throat, congestion/runny nose, earache, or difﬁculty in
breathing.Table 1
Quarterly inﬂuenza data for the study population, November 2009 to October 2010
Nov 09–Jan 10
Q1
Feb 1
Q2
Persons-weeks under surveillance 95 414 191 5
FARI identiﬁed 1515 11
Total inﬂuenza positives (%) 24 
2009A/H1N1 positivity (%) 231 (21) 
Seasonal inﬂuenza positivity (%)a 34 (3) 
Incidence rate of inﬂuenzab (95% CI) 205 (185–227) 
Incidence rate of inﬂuenza A(H1N1)pdm09b (95% CI) 179 (160–199) 
Incidence rate of inﬂuenza Bb (95% CI) 26 (19–35) 
FARI, febrile acute respiratory illness; CI, conﬁdence interval.
a Overall only 2.7% of seasonal inﬂuenza was inﬂuenza A (H3N2); 97.3% was inﬂuen
b Per 1000 person-years.2.3. Specimen collection and inﬂuenza detection
For each FARI episode, combined throat and nasal swabs were
collected from children 1 year of age and adults, and
nasopharyngeal swabs were collected from infants <1 year of
age. US Centers for Disease Control and Prevention real-time RT-
PCR protocols were used for the detection and subtyping of
inﬂuenza viruses, as described previously.9
2.4. Data analysis
Clinical and demographic information on FARI cases was
collected on paper forms at the weekly household visits.
Laboratory results were linked to the FARI surveillance information
in the study database. FARI IRs were calculated by taking the total
number of FARI cases identiﬁed in the age-group for the
numerator, and the total person-time contributed by individuals
who were surveyed each week in the speciﬁc age-group for the
denominator. The proportions of samples positive for each
inﬂuenza subtype in each age group were calculated for each
time period. This positive proportion was then applied to the FARI
IRs to calculate the inﬂuenza IRs overall and by subtype. This
yielded inﬂuenza IRs adjusted for FARI cases from whom either no
respiratory tract samples were obtained or whose samples were
inadequate for testing (unsampled cases). IRs and 95% conﬁdence
intervals (95% CI) were calculated for pandemic inﬂuenza. All
statistical analyses were performed using SAS software version 9.2
(SAS Institute Inc., Cary, NC, USA).
3. Results
3.1. Incidence rates for FARI
The total study population under surveillance for at least 1
week during the 1-year study period was 18 220 individuals. The
study included 14 229 individuals enrolled into the cohort at the
beginning of the study, an additional 3991 individuals who
enrolled during the course of the study, and 1359 cohort members
who dropped out during the study year (withdrawals, deaths, and
migrations). The ﬁnal population under surveillance on October 31,
2010 was 16 861 individuals. Overall, 9395 incident FARI episodes
were recorded with 711 731 person-weeks of observation
completed (Table 1). Weekly surveillance of an average 13 687
household members over the year revealed two distinct peaks of
FARI episodes (EW45–EW52 in 2009 and EW32–EW40 in 2010),
although FARI cases occurred throughout the study period
(Figure 1). Over 50% of the incident FARI episodes occurred in
children aged 0–18 years, with 30% occurring in children 0–5 years
of age. The overall IR for FARI was 686/1000 person-years. The
FARI rate was highest in children 0–5 years of age (1672/10000–Apr 10 May 10–Jul 10
Q3
Aug 10–Oct 10
Q4
Total
32 211 637 213 148 711 731
58 1789 4933 9395
9 10 23 19
1 (0) 10 (1) 507 (13) 749 (10)
88 (9) 143 (9) 396 (10) 661 (9)
28 (23–34) 43 (37–50) 278 (262–294) 128 (122–134)
0 (0–1) 3 (1–5) 156 (144–168) 68 (64–72)
28 (23–34) 40 (34–47) 116 (106–127) 58 (54–62)
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Figure 1. Weekly trend of inﬂuenza positivity during active surveillance in a
community-based study from November 2009 to October 2010 in rural India. The
left axis shows the number positive for seasonal inﬂuenza (red bar: A(H3N2); green
bar: inﬂuenza B) and pandemic A(H1N1)pdm09 (blue); the total number of samples
tested (line) is shown on the right axis. Children aged 6 months to 10 years received
either trivalent seasonal inﬂuenza vaccine (intervention) or inactivated polio
vaccine (control).10
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Figure 2. Incidence rate/1000 person-years for pandemic inﬂuenza A(H1N1)pdm09
in a rural community in North India during the pandemic phase (until July 2010)
and post-pandemic phase (since August 2010). The incidence rates for
A(H1N1)pdm09 were greatest during the ﬁrst pandemic wave from November
2009 to January 2010 (179/1000 person-years), followed by a second peak in the
post-pandemic phase in August–October 2010 (156/1000 person-years), with very
low rates observed (3/1000 person-years) during the inter-pandemic period from
February to July 2010.
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person-years) (Table 2).
3.2. Incidence rates for A(H1N1)pdm09 inﬂuenza
A total of 81% of incident FARI (7571/9395) cases were tested for
inﬂuenza. Among the FARI cases unavailable for inﬂuenza testing,
56% were adults (19 years) and 44% children (<19 years), and
there was no difference in any of the demographic characteristics
of those tested vs. not tested. Of the 7571 specimens tested, 1410
(19%) were positive for inﬂuenza. Of these, 749 (53%) were
inﬂuenza A(H1N1)pdm09, 643 (46%) inﬂuenza B, and 18 (1%)
inﬂuenza A (H3N2) (Table 1). There were two distinct peak periods
of inﬂuenza positivity at EW45–EW52 (November–December) of
2009 and EW32–EW40 (August–October) of 2010, with co-
circulation of inﬂuenza B viruses throughout the study period
(Figure 1). The ﬁrst peak during the pandemic period was almost
exclusively due to inﬂuenza A(H1N1)pdm09 virus. The IR for
inﬂuenza A(H1N1)pdm09 was greatest during the ﬁrst pandemic
phase in November–December 2009 (179/1000 person-years),
followed by a second peak in the post-pandemic phase in August–
October 2010 (156/1000 person-years) (Figure 2; Table 1).
Age-wise distribution of pandemic A(H1N1)pdm09 revealed
the greatest IR in children aged 0–5 years (120/1000 person-years)
and 6–18 years (93/1000 person-years) when compared with
adults (Table 2). Children aged 0–5 years and 6–18 years were
more likely to have A(H1N1)pdm09 (incidence rate ratio (IRR) 2.5,Table 2
Person-weeks under surveillance, febrile acute respiratory illness incidence rates, and 
Age groups,a
years
Person-weeks
under
surveillance
Incident
FARI
cases, n
FARI IR
per 1000
person-years
(95% CI)
Laborat
specime
tested, n
0–5 86 352 2776 1672 (1610–1735) 2460 (8
6–18 186 239 2352 657 (630–684) 1864 (7
19–29 156 183 1357 452 (428–476) 1008 (7
30–44 149 061 1314 458 (434–484) 1004 (7
45–59 83 512 953 593 (556–632) 724 (7
60+ 50 384 643 664 (613–717) 511 (7
Total 711 731 9395 686 (673–700) 7571 (8
FARI, febrile acute respiratory illness; IR, incidence rate; CI, conﬁdence interval.
a Age groups are inclusive.95% CI 2.1–3.0; and IRR 1.9, 95% CI 1.7–2.2, respectively) than
adults aged 19 years and older, indicating that children aged 0–18
years have the greatest IRs for pandemic inﬂuenza in the
community.
4. Discussion
Understanding the incidence of pandemic inﬂuenza is impor-
tant for devising public health responses and mitigation strategies
for pandemic inﬂuenza control. Our study demonstrated high IRs
of A(H1N1)pdm09 in the rural community during the peak
pandemic and post-pandemic periods in the year following the
emergence of pandemic inﬂuenza in North India. The IR of FARI
estimated to be 686/1000 person-years using a population-based
study in a rural village in North India, is at least 10 times higher
than estimated inﬂuenza-like illness rates in a southern province
of China.10 The difference in IRs may be explained partly by the
survey methods (active population survey in the current study vs.
multi-stage stratiﬁed cluster sampling in the latter) or the timing
of the survey (current surveillance implemented during the
pandemic in 2009 vs. 2007 in the China survey). Prospective
analysis of FARI cases over the study period demonstrated
circulation of both pandemic 2009A/H1N1 and inﬂuenza B
(inﬂuenza A (H3N2) was limited) throughout the year. Addition-
ally, pandemic 2009A/H1N1 revealed atypical seasonality, with a
peak in November–December 2009, whereas seasonal inﬂuenzapandemic A(H1N1)pdm09 in rural India from November 2009 to October 2010
ory
ns
 (%)
Inﬂuenza virus
positive,
n (% among tested)
Inﬂuenza
A(H1N1)pdm09
virus positive, n
(% among tested)
Inﬂuenza
A(H1N1)pdm09
IR per 1000
person-years (95% CI)
9) 371 (15) 177 (7) 120 (104–138)
9) 494 (26) 265 (14) 93 (83–104)
4) 231 (23) 134 (13) 60 (51–69)
6) 171 (17) 89 (9) 41 (34–49)
6) 96 (13) 67 (9) 55 (44–68)
9) 47 (9) 17 (3) 22 (13–33)
1) 1410 (19) 749 (10) 68 (64–72)
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area.9
Another unique aspect of our study was the ability to determine
IRs for pandemic A(H1N1)pdm09 during the pandemic and post-
pandemic phases. Using the numbers of persons in the cohort as
the denominator, the overall inﬂuenza A(H1N1)pdm09 incidence
of 6.8% for all age groups identiﬁed in our prospective cohort-based
study is lower than the 11% summary attack rate for all ages
reported in a Hong Kong serosurvey5 and the 16–18% incidence
observed in serosurveys in England.4 The difference in our cohort-
based pandemic inﬂuenza incidence and the serosurvey-based
rates may be due to the study deﬁnition (FARI case deﬁnition with
laboratory conﬁrmed infection vs. the presence of an antibody
response indicating infection, subclinical infection, and/or cross-
reactive antibodies), difference in study populations (rural vs.
urban), or study design (prospective cohort-based vs. pre–post
cohort design). Further we demonstrated that although the
incidence of A(H1N1)pdm09 was highest during the late 2009
pandemic phase, comparable high rates were also observed during
the post-pandemic period from August to October 2010.
In our study population, children (0–18 years) had signiﬁcantly
higher IRs of symptomatic A(H1N1)pdm09 inﬂuenza than adults.
During the ﬁrst wave of pandemic inﬂuenza, analysis of multiple
published studies estimated inﬂuenza IRs to be 34–43% among
school-aged children and 10% in adults in eight countries from four
continents.7,11 Familial clustering studies have shown that
inﬂuenza incidence is greater in children than in adults, and
observational studies have shown that living with children
increases the risk of inﬂuenza infection.7,11 Recent data suggest
that the reduced incidence and severity of infection with
A(H1N1)pdm09 virus in the adult population during the 2009–
2010 inﬂuenza season may have been a result of previous exposure
to seasonal inﬂuenza A viruses.12,13 Our results suggest that
exposure to children should be taken into account for inﬂuenza
research studies, especially for inﬂuenza vaccine efﬁcacy trials in
adults with known familial exposure to children.2
This study has several limitations. First, our use of self-reported
fever in the FARI case deﬁnition may have captured a wide range of
febrile illnesses and overestimated the incidence of true febrile
respiratory illness. However, inﬂuenza incidence was not likely to
be overestimated as the majority of the FARI incident cases were
tested for inﬂuenza by molecular methods. Second, the overall
inﬂuenza rates reported here may have been inﬂuenced by the fact
that almost one-half of the children had received inﬂuenza vaccine
from November 2009 to January 2010.8 While the 2009 seasonal
vaccine did not contain pandemic virus, recent studies have shown
that prior infection with inﬂuenza A (H1N1),12,13 or immunization
with seasonal live attenuated inﬂuenza vaccine, may confer some
cross-protection against the A/(H1N1)pdm09 virus.14,15 Thus, we
believe that the current study likely represents a minimal estimate
of IRs for pandemic inﬂuenza. It is plausible that the true incidence
of A(H1N1)pdm09 may even be greater than the IR we reported for
the pandemic period, since the initial pandemic inﬂuenza peak was
observed during August 2009 in this region but was not captured
because the study reported here had not yet begun.8
The results of this large-scale community-based household
surveillance are important for quantifying inﬂuenza risk at thepopulation level. These data can contribute to global efforts to
estimate burden of seasonal and pandemic inﬂuenza, which are
useful for advocacy for strengthening inﬂuenza prevention and
control efforts. At a national level, such studies provide important
information for planning clinical and public health intervention
strategies to mitigate the impact of inﬂuenza epidemics.
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